GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (FRA:BV3) » Definitions » Cyclically Adjusted PB Ratio

Bavarian Nordic A/S (FRA:BV3) Cyclically Adjusted PB Ratio : 2.05 (As of May. 03, 2024)


View and export this data going back to . Start your Free Trial

What is Bavarian Nordic A/S Cyclically Adjusted PB Ratio?

As of today (2024-05-03), Bavarian Nordic A/S's current share price is €20.64. Bavarian Nordic A/S's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €10.06. Bavarian Nordic A/S's Cyclically Adjusted PB Ratio for today is 2.05.

The historical rank and industry rank for Bavarian Nordic A/S's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:BV3' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.81   Med: 3.52   Max: 8.59
Current: 2

During the past years, Bavarian Nordic A/S's highest Cyclically Adjusted PB Ratio was 8.59. The lowest was 1.81. And the median was 3.52.

FRA:BV3's Cyclically Adjusted PB Ratio is ranked worse than
54.5% of 644 companies
in the Biotechnology industry
Industry Median: 1.74 vs FRA:BV3: 2.00

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bavarian Nordic A/S's adjusted book value per share data for the three months ended in Dec. 2023 was €17.798. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €10.06 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bavarian Nordic A/S Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Bavarian Nordic A/S's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic A/S Cyclically Adjusted PB Ratio Chart

Bavarian Nordic A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.19 3.97 4.97 3.28 2.38

Bavarian Nordic A/S Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.28 2.89 2.78 2.19 2.38

Competitive Comparison of Bavarian Nordic A/S's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Bavarian Nordic A/S's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bavarian Nordic A/S's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic A/S's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic A/S's Cyclically Adjusted PB Ratio falls into.



Bavarian Nordic A/S Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Bavarian Nordic A/S's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=20.64/10.06
=2.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bavarian Nordic A/S's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Bavarian Nordic A/S's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=17.798/116.7000*116.7000
=17.798

Current CPI (Dec. 2023) = 116.7000.

Bavarian Nordic A/S Quarterly Data

Book Value per Share CPI Adj_Book
201403 3.974 99.600 4.656
201406 3.759 99.700 4.400
201409 3.585 99.700 4.196
201412 4.810 99.400 5.647
201503 4.850 100.200 5.649
201506 5.143 100.300 5.984
201509 4.964 100.200 5.781
201512 5.077 99.800 5.937
201603 4.170 100.200 4.857
201606 6.223 100.600 7.219
201609 6.485 100.200 7.553
201612 6.844 100.300 7.963
201703 6.905 101.200 7.963
201706 7.178 101.200 8.277
201709 8.770 101.800 10.054
201712 8.268 101.300 9.525
201803 7.675 101.700 8.807
201806 7.407 102.300 8.450
201809 7.483 102.400 8.528
201812 7.167 102.100 8.192
201903 6.857 102.900 7.777
201906 6.508 102.900 7.381
201909 6.203 102.900 7.035
201912 6.112 102.900 6.932
202003 11.728 103.300 13.249
202006 12.048 103.200 13.624
202009 12.131 103.500 13.678
202012 11.276 103.400 12.726
202103 12.509 104.300 13.996
202106 12.219 105.000 13.581
202109 12.136 105.800 13.386
202112 14.096 106.600 15.432
202203 13.596 109.900 14.437
202206 13.142 113.600 13.501
202209 13.252 116.400 13.286
202212 13.615 115.900 13.709
202303 15.765 117.300 15.684
202306 16.729 116.400 16.772
202309 16.098 117.400 16.002
202312 17.798 116.700 17.798

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bavarian Nordic A/S  (FRA:BV3) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Bavarian Nordic A/S Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic A/S's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bavarian Nordic A/S (FRA:BV3) Business Description

Traded in Other Exchanges
Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.

Bavarian Nordic A/S (FRA:BV3) Headlines

No Headlines